
World's First Allogeneic Artificial Regenerated Platelet Clinical Study Succeeds in Shanghai
Shanghai Children's Medical Center completed the world's first iPLT clinical infusion study, transfusing patients with acute leukemia, aplastic anemia, and post-operative complex congenital heart disease, preliminarily confirming safety and good tolerability.
Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

